These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3509398)

  • 1. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
    Mini E; Mazzei T; Periti P; Reali EF; Bordonaro P; Balocchini E; Ninu B
    Chemioterapia; 1987 Jun; 6(2 Suppl):243-6. PubMed ID: 3509398
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbiological and pharmacokinetic evaluation of cefonicid, a long-acting cephalosporin.
    Mini E; Mazzei T; Periti P; Reali EF; Bordonaro P; Balocchini E; Ninu B
    Chemioterapia; 1987 Apr; 6(2):95-8. PubMed ID: 3594635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penetration of cefonicid in skin suction blister fluid in healthy volunteers.
    Cruciani M; Concia E; Passarella E; Soncini R
    Int J Clin Pharmacol Res; 1987; 7(3):225-7. PubMed ID: 3596863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefonicid, a long acting cephalosporin: in vitro activity compared with three cephalosporins and gentamicin.
    Hamilton-Miller JM; Patel R; Brumfitt W
    Drugs Exp Clin Res; 1986; 12(11):861-9. PubMed ID: 3816503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefonicid sodium (Monocid).
    Med Lett Drugs Ther; 1984 Aug; 26(667):71-2. PubMed ID: 6379400
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized clinical trial comparing the safety and efficacy of cefonicid and cefamandole in the treatment of patients with respiratory tract infections caused by susceptible pathogens.
    Azanza JR; Honorato J; Rubio A; Cuena R
    Chemioterapia; 1987 Jun; 6(2 Suppl):449-51. PubMed ID: 3334597
    [No Abstract]   [Full Text] [Related]  

  • 7. Cefonicid concentration in lung tissue after intramuscular administration.
    Cruciani M; Savio S; Concia E
    Int J Clin Pharmacol Res; 1987; 7(6):481-4. PubMed ID: 3440639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro sensitivity of hospital-isolated pathogenic bacterial strains to 4 different cephalosporins: cephaloridine, cefotaxime, cefoxitin, cefonicid].
    Rosina M; Mauri J; Germiniani R; Mastropasqua E; Figini G
    Minerva Chir; 1986 Aug; 41(15-16):1347-51. PubMed ID: 3774182
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of the new second-generation cephalosporins: cefonicid, ceforanide, and cefuroxime.
    Tartaglione TA; Polk RE
    Drug Intell Clin Pharm; 1985 Mar; 19(3):188-98. PubMed ID: 3884304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum.
    Barry AL; Jones RN; Packer RR
    Antimicrob Agents Chemother; 1986 Jan; 29(1):147-9. PubMed ID: 3729326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the cefonicid disk test criteria, including disk quality control guidelines.
    Barry AL; Jones RN; Thornsberry C
    J Clin Microbiol; 1983 Feb; 17(2):232-9. PubMed ID: 6601113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefonicid kinetics in subjects with normal and impaired renal function.
    Blair AD; Maxwell BM; Forland SC; Jacob L; Cutler RE
    Clin Pharmacol Ther; 1984 Jun; 35(6):798-803. PubMed ID: 6734031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of agar-disc-diffusion tests with minimum inhibitory concentrations of cefonicid (SK&F 75073) and cephalothin.
    Grappel SF; Guarini JR; Actor P; Weisbach JA
    J Antibiot (Tokyo); 1980 Jan; 33(1):85-7. PubMed ID: 7372555
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of cefonicid in serum and its penetration into lung tissue, bronchial mucosa and pleura.
    Furlan G; Besa G; Broccali G; Gusmitta A
    Int J Clin Pharmacol Res; 1989; 9(1):49-53. PubMed ID: 2707925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of cefonicid on the pharmacokinetics of a once-a-day theophylline formulation.
    Cazzola M; Lobefalo G; Lupis F; Vanacore L; Martucci P; D'Amato G
    Int J Clin Pharmacol Res; 1989; 9(3):169-73. PubMed ID: 2663736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefonicid in children.
    Furlanut M; D'Elia R; Riva E; Pasinelli F
    Eur J Clin Pharmacol; 1989; 36(1):79-82. PubMed ID: 2917594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefonicid: a long-acting, second-generation cephalosporin. Antimicrobial activity, pharmacokinetics, clinical efficacy and adverse effects.
    Pontzer RE; Kaye D
    Pharmacotherapy; 1984; 4(6):325-33. PubMed ID: 6393074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protein binding on drug penetration into blister fluid.
    Shyu WC; Quintiliani R; Nightingale CH; Dudley MN
    Antimicrob Agents Chemother; 1988 Jan; 32(1):128-30. PubMed ID: 3162360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ceforanide. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
    Campoli-Richards DM; Lackner TE; Monk JP
    Drugs; 1987 Oct; 34(4):411-37. PubMed ID: 3315624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysis.
    Barriere SL; Gambertoglio JG; Alexander DP; Stagg RJ; Conte JE
    Rev Infect Dis; 1984; 6 Suppl 4():S809-15. PubMed ID: 6522922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.